Global Point of Care and Rapid Diagnostic Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Point of Care and Rapid Diagnostic market report explains the definition, types, applications, major countries, and major players of the Point of Care and Rapid Diagnostic market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Danaher Corporation

    • Abbott Laboratories

    • Roche Diagnostics

    • EKF Diagnostics

    • Fluxergy

    • Quidel Diagnostics

    • Becton Dickinson and Company

    • Trinity Biotech

    • Siemens Healthineers

    • Chembio Diagnostics

    By Type:

    • SBMG

    • Infectious Disease

    • Coagulation

    By End-User:

    • Hospital

    • Digital Diagnostic

    • Homecare

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Point of Care and Rapid Diagnostic Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Point of Care and Rapid Diagnostic Outlook to 2028- Original Forecasts

    • 2.2 Point of Care and Rapid Diagnostic Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Point of Care and Rapid Diagnostic Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Point of Care and Rapid Diagnostic Market- Recent Developments

    • 6.1 Point of Care and Rapid Diagnostic Market News and Developments

    • 6.2 Point of Care and Rapid Diagnostic Market Deals Landscape

    7 Point of Care and Rapid Diagnostic Raw Materials and Cost Structure Analysis

    • 7.1 Point of Care and Rapid Diagnostic Key Raw Materials

    • 7.2 Point of Care and Rapid Diagnostic Price Trend of Key Raw Materials

    • 7.3 Point of Care and Rapid Diagnostic Key Suppliers of Raw Materials

    • 7.4 Point of Care and Rapid Diagnostic Market Concentration Rate of Raw Materials

    • 7.5 Point of Care and Rapid Diagnostic Cost Structure Analysis

      • 7.5.1 Point of Care and Rapid Diagnostic Raw Materials Analysis

      • 7.5.2 Point of Care and Rapid Diagnostic Labor Cost Analysis

      • 7.5.3 Point of Care and Rapid Diagnostic Manufacturing Expenses Analysis

    8 Global Point of Care and Rapid Diagnostic Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Point of Care and Rapid Diagnostic Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Point of Care and Rapid Diagnostic Export by Region (Top 10 Countries) (2017-2028)

    9 Global Point of Care and Rapid Diagnostic Market Outlook by Types and Applications to 2022

    • 9.1 Global Point of Care and Rapid Diagnostic Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global SBMG Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Infectious Disease Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Coagulation Consumption and Growth Rate (2017-2022)

    • 9.2 Global Point of Care and Rapid Diagnostic Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Digital Diagnostic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Homecare Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Point of Care and Rapid Diagnostic Market Analysis and Outlook till 2022

    • 10.1 Global Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.2.2 Canada Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.2.3 Mexico Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.2 UK Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.3 Spain Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.4 Belgium Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.5 France Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.6 Italy Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.7 Denmark Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.8 Finland Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.9 Norway Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.10 Sweden Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.11 Poland Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.12 Russia Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.3.13 Turkey Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.2 Japan Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.3 India Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.4 South Korea Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.5 Pakistan Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.6 Bangladesh Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.7 Indonesia Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.8 Thailand Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.9 Singapore Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.10 Malaysia Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.11 Philippines Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.4.12 Vietnam Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.2 Colombia Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.3 Chile Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.4 Argentina Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.5 Venezuela Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.6 Peru Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.7 Puerto Rico Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.5.8 Ecuador Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.6.2 Kuwait Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.6.3 Oman Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.6.4 Qatar Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.7.2 South Africa Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.7.3 Egypt Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.7.4 Algeria Point of Care and Rapid Diagnostic Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Point of Care and Rapid Diagnostic Consumption (2017-2022)

      • 10.8.2 New Zealand Point of Care and Rapid Diagnostic Consumption (2017-2022)

    11 Global Point of Care and Rapid Diagnostic Competitive Analysis

    • 11.1 Danaher Corporation

      • 11.1.1 Danaher Corporation Company Details

      • 11.1.2 Danaher Corporation Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Danaher Corporation Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.1.4 Danaher Corporation Point of Care and Rapid Diagnostic Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Abbott Laboratories

      • 11.2.1 Abbott Laboratories Company Details

      • 11.2.2 Abbott Laboratories Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Abbott Laboratories Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.2.4 Abbott Laboratories Point of Care and Rapid Diagnostic Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Roche Diagnostics

      • 11.3.1 Roche Diagnostics Company Details

      • 11.3.2 Roche Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Roche Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.3.4 Roche Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 EKF Diagnostics

      • 11.4.1 EKF Diagnostics Company Details

      • 11.4.2 EKF Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 EKF Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.4.4 EKF Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Fluxergy

      • 11.5.1 Fluxergy Company Details

      • 11.5.2 Fluxergy Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Fluxergy Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.5.4 Fluxergy Point of Care and Rapid Diagnostic Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Quidel Diagnostics

      • 11.6.1 Quidel Diagnostics Company Details

      • 11.6.2 Quidel Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Quidel Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.6.4 Quidel Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Becton Dickinson and Company

      • 11.7.1 Becton Dickinson and Company Company Details

      • 11.7.2 Becton Dickinson and Company Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Becton Dickinson and Company Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.7.4 Becton Dickinson and Company Point of Care and Rapid Diagnostic Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Trinity Biotech

      • 11.8.1 Trinity Biotech Company Details

      • 11.8.2 Trinity Biotech Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Trinity Biotech Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.8.4 Trinity Biotech Point of Care and Rapid Diagnostic Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Siemens Healthineers

      • 11.9.1 Siemens Healthineers Company Details

      • 11.9.2 Siemens Healthineers Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Siemens Healthineers Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.9.4 Siemens Healthineers Point of Care and Rapid Diagnostic Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Chembio Diagnostics

      • 11.10.1 Chembio Diagnostics Company Details

      • 11.10.2 Chembio Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Chembio Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

      • 11.10.4 Chembio Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Point of Care and Rapid Diagnostic Market Outlook by Types and Applications to 2028

    • 12.1 Global Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global SBMG Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Coagulation Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Digital Diagnostic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Point of Care and Rapid Diagnostic Market Analysis and Outlook to 2028

    • 13.1 Global Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.2.2 Canada Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.2 UK Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.3 Spain Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.5 France Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.6 Italy Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.8 Finland Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.9 Norway Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.11 Poland Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.12 Russia Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.2 Japan Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.3 India Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.3 Chile Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.6 Peru Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.6.3 Oman Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Point of Care and Rapid Diagnostic Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Point of Care and Rapid Diagnostic

    • Figure of Point of Care and Rapid Diagnostic Picture

    • Table Global Point of Care and Rapid Diagnostic Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Point of Care and Rapid Diagnostic Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global SBMG Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Coagulation Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Digital Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Table North America Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure United States Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Canada Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Mexico Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Europe Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure Germany Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure UK Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Spain Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Belgium Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure France Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Italy Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Denmark Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Finland Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Norway Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Sweden Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Poland Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Russia Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Turkey Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table APAC Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure China Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Japan Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure India Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure South Korea Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Thailand Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Singapore Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Philippines Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table South America Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure Brazil Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Colombia Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Chile Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Argentina Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Peru Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table GCC Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure Bahrain Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Oman Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Qatar Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Africa Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure Nigeria Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure South Africa Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Egypt Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Algeria Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Oceania Point of Care and Rapid Diagnostic Consumption by Country (2017-2022)

    • Figure Australia Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Point of Care and Rapid Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Danaher Corporation Company Details

    • Table Danaher Corporation Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Danaher Corporation Point of Care and Rapid Diagnostic Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Abbott Laboratories Point of Care and Rapid Diagnostic Product Portfolio

    • Table Roche Diagnostics Company Details

    • Table Roche Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Roche Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

    • Table EKF Diagnostics Company Details

    • Table EKF Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table EKF Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table EKF Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

    • Table Fluxergy Company Details

    • Table Fluxergy Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fluxergy Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Fluxergy Point of Care and Rapid Diagnostic Product Portfolio

    • Table Quidel Diagnostics Company Details

    • Table Quidel Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quidel Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Quidel Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

    • Table Becton Dickinson and Company Company Details

    • Table Becton Dickinson and Company Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson and Company Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Becton Dickinson and Company Point of Care and Rapid Diagnostic Product Portfolio

    • Table Trinity Biotech Company Details

    • Table Trinity Biotech Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trinity Biotech Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Trinity Biotech Point of Care and Rapid Diagnostic Product Portfolio

    • Table Siemens Healthineers Company Details

    • Table Siemens Healthineers Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Siemens Healthineers Point of Care and Rapid Diagnostic Product Portfolio

    • Table Chembio Diagnostics Company Details

    • Table Chembio Diagnostics Point of Care and Rapid Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chembio Diagnostics Point of Care and Rapid Diagnostic Main Business and Markets Served

    • Table Chembio Diagnostics Point of Care and Rapid Diagnostic Product Portfolio

    • Figure Global SBMG Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coagulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Digital Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Table North America Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure United States Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Germany Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure China Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Brazil Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Point of Care and Rapid Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Australia Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Point of Care and Rapid Diagnostic Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.